NRP1 antagonist 1
Zilucoplan
Vesencumab
Ravulizumab
Lampalizumab
Tesidolumab
Avdoralimab
Vilobelimab
Pexelizumab
Gefurulimab
Gavilimomab
Olendalizumab
Crovalimab
Pozelimab
Riliprubart
Empasiprubart
Zoracopan
BCX 1470
Sutimlimab
PMX 205